Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 4

Results: 13

DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 409, doi. 10.1007/s00262-014-1648-2

By:

Wu, Ming-Ru;
Zhang, Tong;
Alcon, Andre;
Sentman, Charles

Publication type:

Article

Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 467, doi. 10.1007/s00262-015-1658-8

By:

Okroj, Marcin;
Holmquist, Emelie;
Nilsson, Elise;
Anagnostaki, Lola;
Jirström, Karin;
Blom, Anna

Publication type:

Article

The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 459, doi. 10.1007/s00262-014-1652-6

By:

Hughes, Tasha;
Klairmont, Matthew;
Broucek, Joseph;
Iodice, Gail;
Basu, Sanjib;
Kaufman, Howard

Publication type:

Article

Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008).

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 437, doi. 10.1007/s00262-015-1653-0

By:

Lacouture, Mario;
Morris, John;
Lawrence, Donald;
Tan, Antoinette;
Olencki, Thomas;
Shapiro, Geoffrey;
Dezube, Bruce;
Berzofsky, Jay;
Hsu, Frank;
Guitart, Joan

Publication type:

Article

Enhancement of glioma-specific immunity in mice by 'NOBEL', an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 447, doi. 10.1007/s00262-015-1654-z

By:

Morin-Brureau, Mélanie;
Hooper, Kirsten;
Prosniak, Michael;
Sauma, Sami;
Harshyne, Larry;
Andrews, David;
Hooper, D.

Publication type:

Article

Low-dose cyclophosphamide enhances antigen-specific CD4 T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 507, doi. 10.1007/s00262-015-1656-x

By:

Klein, Oliver;
Davis, Ian;
McArthur, Grant;
Chen, Li;
Haydon, Andrew;
Parente, Phillip;
Dimopoulos, Nektaria;
Jackson, Heather;
Xiao, Kun;
Maraskovsky, Eugene;
Hopkins, Wendie;
Stan, Rodica;
Chen, Weisan;
Cebon, Jonathan

Publication type:

Article

Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 419, doi. 10.1007/s00262-014-1651-7

By:

Sayour, Elias;
McLendon, Pat;
McLendon, Roger;
Leon, Gabriel;
Reynolds, Renee;
Kresak, Jesse;
Sampson, John;
Mitchell, Duane

Publication type:

Article

Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 479, doi. 10.1007/s00262-015-1659-7

By:

Quiroga, Dionisia;
Aldhamen, Yasser;
Appledorn, Daniel;
Godbehere, Sarah;
Amalfitano, Andrea

Publication type:

Article

Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 493, doi. 10.1007/s00262-015-1660-1

By:

Noguchi, Masanori;
Arai, Gaku;
Matsumoto, Kazumasa;
Naito, Seiji;
Moriya, Fukuko;
Suekane, Shigetaka;
Komatsu, Nobukazu;
Matsueda, Satoko;
Sasada, Tetsuro;
Yamada, Akira;
Kakuma, Tatsuyuki;
Itoh, Kyogo

Publication type:

Article

'Tumor immunology meets oncology' (TIMO) X, May 23-24, 2014, Halle/Saale, Germany.

Published in:

2015

By:

Quandt, Dagmar;
Seliger, Barbara

Publication type:

Report

Prostate cancer vaccines: the long road to clinical application.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 401, doi. 10.1007/s00262-015-1667-7

By:

Baxevanis, Constantin;
Papamichail, Michael;
Perez, Sonia

Publication type:

Article

Acknowledgement.

Published in:: Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 527, doi. 10.1007/s00262-015-1673-9
Publication type:: Article

Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 429, doi. 10.1007/s00262-014-1644-6

By:

Ito, Hiroyasu;
Ando, Tatsuya;
Ogiso, Hideyuki;
Arioka, Yuko;
Seishima, Mitsuru

Publication type:

Article